Douglas C. Harnish

2.2k total citations
35 papers, 1.9k citations indexed

About

Douglas C. Harnish is a scholar working on Genetics, Oncology and Molecular Biology. According to data from OpenAlex, Douglas C. Harnish has authored 35 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Genetics, 16 papers in Oncology and 14 papers in Molecular Biology. Recurrent topics in Douglas C. Harnish's work include Estrogen and related hormone effects (19 papers), NF-κB Signaling Pathways (9 papers) and Drug Transport and Resistance Mechanisms (8 papers). Douglas C. Harnish is often cited by papers focused on Estrogen and related hormone effects (19 papers), NF-κB Signaling Pathways (9 papers) and Drug Transport and Resistance Mechanisms (8 papers). Douglas C. Harnish collaborates with scholars based in United States, Canada and Australia. Douglas C. Harnish's co-authors include Mark J. Evans, Songwen Zhang, KehDih Lai, Juan Wang, Sotirios K. Karathanasis, Steven J. Adelman, A Eckert, Marshall S. Scicchitano, Lisa Borges-Marcucci and Christopher C. Chadwick and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Douglas C. Harnish

35 papers receiving 1.8k citations

Peers

Countries citing papers authored by Douglas C. Harnish

Since Specialization

Citations

This map shows the geographic impact of Douglas C. Harnish's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas C. Harnish with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas C. Harnish more than expected).

Fields of papers citing papers by Douglas C. Harnish

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas C. Harnish. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas C. Harnish. The network helps show where Douglas C. Harnish may publish in the future.

Co-authorship network of co-authors of Douglas C. Harnish

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas C. Harnish. A scholar is included among the top collaborators of Douglas C. Harnish based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas C. Harnish. Douglas C. Harnish is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Improvement of Physiochemical Properties of the Tetrahydroazepinoindole Series of Farnesoid X Receptor (FXR) Agonists: Beneficial Modulation of Lipids in Primates 2010 ·Journal of Medicinal Chemistry ·Joseph T. Lundquist, Douglas C. Harnish, (unknown), John F. Mehlmann, Rayomand J. Unwalla, (unknown), Matthew L. Crawley, (unknown), Daniel M. Green, Weixin Xu, Wah-Tung Hum, (unknown), Irene Feingold, (unknown), Mark J. Evans, KehDih Lai, Lisa Borges-Marcucci, Paige E. Mahaney, Jay Wrobel	42
2	A synthetic farnesoid X receptor (FXR) agonist promotes cholesterol lowering in models of dyslipidemia 2009 ·American Journal of Physiology-Gastrointestinal and Liver Physiology ·Mark J. Evans, Paige E. Mahaney, Lisa Borges-Marcucci, KehDih Lai, Shuguang Wang, Julie A. Krueger, Stephen J. Gardell, Christine Huard, (unknown), George P. Vlasuk, Douglas C. Harnish	79
3	CRP is a novel ligand for the oxidized LDL receptor LOX-1 2009 ·American Journal of Physiology-Heart and Circulatory Physiology ·Heather H. Shih, Songwen Zhang, Wei Cao, Ashleigh Hahn, Juan Wang, Janet Paulsen, Douglas C. Harnish	60
4	Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis 2009 ·Journal of Hepatology ·Songwen Zhang, Juan Wang, (unknown), Douglas C. Harnish	256
5	Pyrrole[2,3-d]azepino compounds as agonists of the farnesoid X receptor (FXR) 2009 ·Bioorganic & Medicinal Chemistry Letters ·John F. Mehlmann, Matthew L. Crawley, Joseph T. Lundquist, Ray Unwalla, Douglas C. Harnish, Mark J. Evans, (unknown), Jay Wrobel, Paige E. Mahaney	19
6	Oligomerization is required for the activity of recombinant soluble LOX‐1 2009 ·FEBS Journal ·Wei Cao, Valérie Calabro, (unknown), Grace Yan, (unknown), Stéphane Olland, (unknown), (unknown), Richard Zollner, Zhijian Lu, (unknown), (unknown), Lioudmila Tchistiakova, Davinder Gill, Douglas C. Harnish, Janet Paulsen, Heather H. Shih	26
7	Control of Chronic Inflammation with Pathway Selective Estrogen Receptor Ligands 2006 ·Current Topics in Medicinal Chemistry ·Robert J. Steffan, Edward Matelan, Mark A. Ashwell, William Moore, (unknown), Eugene J. Trybulski, Christopher C. Chadwick, Susan Chippari, Thomas Kenney, Richard C. Winneker, A Eckert, Lisa Borges-Marcucci, Steven J. Adelman, Xu Zhang, (unknown), Douglas C. Harnish	11
8	The utility of pathway selective estrogen receptor ligands that inhibit nuclear factor-κB transcriptional activity in models of rheumatoid arthritis 2005 ·Arthritis Research & Therapy ·James C. Keith, Leo Albert, (unknown), Max Follettie, (unknown), Lisa Borges-Marcucci, Christopher C. Chadwick, Robert J. Steffan, Douglas C. Harnish	48
9	THE ACTIVITY OF PATHWAY-SELECTIVE ESTROGEN RECEPTOR LIGANDS IN EXPERIMENTAL SEPTIC SHOCK 2005 ·Shock ·Steven M. Opal, John E. Palardy, Patricia Cristofaro, Nicolas A. Parejo, Jhung W. Jhung, James C. Keith, (unknown), (unknown), Robert J. Steffan, Christopher C. Chadwick, Douglas C. Harnish	7
10	Bile acid signaling through FXR induces intracellular adhesion molecule-1 expression in mouse liver and human hepatocytes 2005 ·American Journal of Physiology-Gastrointestinal and Liver Physiology ·(unknown), Lisa Borges-Marcucci, Mark J. Evans, Douglas C. Harnish	39
11	Substituted 4-hydroxyphenyl sulfonamides as pathway-selective estrogen receptor ligands 2005 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Mark A. Ashwell, Eugene J. Trybulski, (unknown), William Moore, Douglas C. Harnish, Christopher C. Chadwick	5
12	Beneficial effects of estrogen treatment in the HLA-B27 transgenic rat model of inflammatory bowel disease 2004 ·American Journal of Physiology-Gastrointestinal and Liver Physiology ·Douglas C. Harnish, Leo Albert, (unknown), A Eckert, A. Ciarletta, Marion T. Kasaian, James C. Keith	96
13	Estrogen Receptor α Regulates Expression of the Orphan Receptor Small Heterodimer Partner 2003 ·Journal of Biological Chemistry ·KehDih Lai, Douglas C. Harnish, Mark J. Evans	70
14	Estrogen Regulation of the Apolipoprotein AI Gene Promoter through Transcription Cofactor Sharing 1998 ·Journal of Biological Chemistry ·Douglas C. Harnish, Mark J. Evans, Marshall S. Scicchitano, (unknown), Sotirios K. Karathanasis	77
15	Control of Apolipoprotein AI Gene Expression through Synergistic Interactions between Hepatocyte Nuclear Factors 3 and 4 1996 ·Journal of Biological Chemistry ·Douglas C. Harnish, Sohail Malik, Edward J. Kilbourne, Robert H. Costa, Sotirios K. Karathanasis	77
16	Involvement of Early Growth Response Factor Egr-1 in Apolipoprotein AI Gene Transcription 1995 ·Journal of Biological Chemistry ·Edward J. Kilbourne, Russell L. Widom, Douglas C. Harnish, Sohail Malik, Sotirios K. Karathanasis	50
17	A sustained elevation in retinoic acid receptor-β2 mRNA and protein occurs during retinoic acid-induced fetal dysmorphogenesis 1994 ·Mechanisms of Development ·Dianne Robert Soprano, Michael Gyda, Heng Jiang, Douglas C. Harnish, (unknown), Michael Satre, Lan Chen, Kenneth J. Soprano, D. M. Kochhar	27
18	Mouse conceptuses have a limited capacity to elevate the mRNA level of cellular retinoid binding proteins in response to teratogenic doses of retinoic acid 1992 ·Teratology ·Douglas C. Harnish, Kenneth J. Soprano, Dianne Robert Soprano	12
19	Retinoic acid receptor β2 mRNA is elevated by retinoic acid in vivo in susceptible regions of mid‐gestation mouse embryos 1992 ·Developmental Dynamics ·Douglas C. Harnish, Heng Jiang, Kenneth J. Soprano, D. M. Kochhar, Dianne Robert Soprano	35
20	Induction of β-retinoic acid receptor mRNA by teratogenic doses of retinoids in murine fetuses 1990 ·Differentiation ·Douglas C. Harnish, Arun B. Barua, Kenneth J. Soprano, Dianne Robert Soprano	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact